Better Context → Better Decisions

Context counts in life sciences. The FENIX analyst team is tirelessly using its experience to put you in a position to succeed. Below, our readers without corporate access will find a wealth of contextualized life science insight ready to be purchased in the FENIX Marketplace. If our content sharing limitations are inconvenient for you, reach out to Brady for unlimited corporate, institutional, or individual access.

lilly cover image
$599
 Posted in: Dual/triple agonist May 07 | 2019LY3305677 Lilly's Oxyntomodulin? New Ph1 Trial ObservedPurchase Blast
novo cover image
$599
 Posted in: Basal Insulin, GLP-1RA May 07 | 2019Novo Q1 '19 London Earnings UpdatePurchase Blast
astrazeneca cover image
$599
 Posted in: DPP-IVi, SGLT2i May 03 | 2019AZ Triple Combo Approved as Qternmet XR; Qtern Label UpdatePurchase Blast
novo cover image
$599
 Posted in: Basal Insulin, GLP-1RA May 03 | 2019Tresiba Hypo Benefit Over Toujeo; Novo Q1 '19 Earnings UpdatePurchase Blast
insulet cover image
$599
 Posted in: Insulin Delivery May 02 | 2019Insulet Q1 '19 Earnings UpdatePurchase Blast
dexcom cover image
$599
 Posted in: Glucose Monitoring May 01 | 2019Dexcom Q1 '19 Earnings UpdatePurchase Blast
lexicon cover image
$599
 Posted in: SGLT2i May 01 | 2019No Update on Sota CRL Resolution Timeline; Lexicon Q1 '19 Earnings UpdatePurchase Blast
tandem cover image
$599
 Posted in: Insulin Delivery Apr 30 | 2019Tandem Q1 '19 Earnings UpdatePurchase Blast
merck and pfizer cover image
$599
 Posted in: DPP-IVi, GLP-1RA, SGLT2i Apr 30 | 2019Merck and Pfizer Q1 '19 Earnings UpdatesPurchase Blast
lilly cover image
Free
 Posted in: Basal Insulin, Bolus Insulin, DPP-IVi, Dual/triple agonist, GLP-1RA, Glucagon, Glucose Monitoring, Insulin Delivery, SGLT2i Apr 30 | 2019REWIND Filed; Empa T1DM, Nasal Glucagon Delayed; Lilly Q1 '19 Earnings UpdateAccess Free Blast
novo cover image
$599
 Posted in: GLP-1RA Apr 29 | 2019Victoza Pediatric Trial (ELLIPSE) Results and Regulatory FilingsPurchase Blast
biocon cover image
$599
 Posted in: Basal Insulin, Bolus Insulin Apr 26 | 2019Biocon CY Q1 '19 (FY Q4 '19) Earnings UpdatePurchase Blast
lexicon and sanofi cover image
$599
 Posted in: SGLT2i Apr 26 | 2019Zynquista Approved in EU for T1DMPurchase Blast
lilly cover image
$599
 Posted in: Bolus Insulin Apr 26 | 2019Lispro AG Excluded from ESI 2019 Commercial FormularyPurchase Blast
sanofi cover image
$599
 Posted in: Basal Insulin, Bolus Insulin, Dual/triple agonist, GLP-1RA, GLP-1RA + Basal Apr 26 | 2019No Sotagliflozin CRL Clarity; Sanofi Q1 '19 Earnings UpdatePurchase Blast
astrazeneca cover image
$599
 Posted in: GLP-1RA, SGLT2i Apr 26 | 2019DECLARE Filing Accepted; AZ Q1 '19 Earnings UpdatePurchase Blast
lilly cover image
$599
 Posted in: Glucagon Apr 22 | 2019No Lilly Nasal Glucagon Update?Purchase Blast
novo cover image
$599
 Posted in: GLP-1RA Apr 18 | 2019Novo Oral Sema CVOT Initiated (SOUL)Purchase Blast
roche and abbott cover image
$599
 Posted in: Glucose Monitoring Apr 17 | 2019Abbott and Roche Q1 '19 Earnings UpdatesPurchase Blast
JnJ cover image
$599
 Posted in: SGLT2i Apr 16 | 2019JnJ Q1 '19 Earnings UpdatePurchase Blast
1 … 73 74 75 76 77 … 95

Get the Latest Analysis

Stay informed and aligned with frequent updates to keep a pulse on the industry.

If you already have an account, please log in. If you have any questions or would like to subscribe to our services, please contact Brady.

Contact BradyLog In